ReviewInternational journal of molecular sciences2022

Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer.

Adrian Dumitru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.